• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性活动性肝炎患者短期泼尼松龙治疗后的甾醇和胆汁酸代谢

Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.

作者信息

Yamanishi Y, Nosaka Y, Kawasaki H, Hirayama C, Ikawa S

出版信息

Gastroenterol Jpn. 1985 Jun;20(3):246-51. doi: 10.1007/BF02774711.

DOI:10.1007/BF02774711
PMID:4043657
Abstract

Serum levels of squalene, cholesterol and bile acid were measured before and after short-term prednisolone administration in patients with chronic active hepatitis. Comparison with normal controls indicated that serum bile acid levels were increased significantly (p less than 0.01) in patients with chronic active hepatitis, but serum levels of squalene and cholesterol did not differ significantly between the two groups. After short-term prednisolone treatment, serum levels of squalene and cholesterol were increased significantly (p less than 0.01) as compared with the pretreatment level. On the other hand, while serum fasting bile acid levels were found to be increased significantly (p less than 0.01), serum clearance after oral administration of ursodeoxycholic acid improved significantly (p less than 0.05) after treatment. These results indicated that short-term prednisolone treatment increases sterol metabolism in the liver in patients with chronic active hepatitis, resulting from an increase in hepatic clearance of bile acids.

摘要

在慢性活动性肝炎患者中,测定了短期给予泼尼松龙前后血清中角鲨烯、胆固醇和胆汁酸的水平。与正常对照组相比,慢性活动性肝炎患者血清胆汁酸水平显著升高(p<0.01),但两组间血清角鲨烯和胆固醇水平无显著差异。短期泼尼松龙治疗后,与治疗前水平相比,血清角鲨烯和胆固醇水平显著升高(p<0.01)。另一方面,虽然空腹血清胆汁酸水平显著升高(p<0.01),但治疗后口服熊去氧胆酸后的血清清除率显著改善(p<0.05)。这些结果表明,短期泼尼松龙治疗可增加慢性活动性肝炎患者肝脏中的甾醇代谢,这是由于胆汁酸肝清除率增加所致。

相似文献

1
Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.慢性活动性肝炎患者短期泼尼松龙治疗后的甾醇和胆汁酸代谢
Gastroenterol Jpn. 1985 Jun;20(3):246-51. doi: 10.1007/BF02774711.
2
Biliary squalene levels in hepatobiliary disease.肝胆疾病中的胆汁角鲨烯水平。
Gastroenterol Jpn. 1985 Aug;20(4):338-43. doi: 10.1007/BF02774744.
3
Relationships between squalene and cholesterol in bile: effect of ursodeoxycholic acid administration in patients with radiolucent gallstones.胆汁中角鲨烯与胆固醇的关系:熊去氧胆酸给药对透X线胆结石患者的影响
Metabolism. 1984 Jul;33(7):641-5. doi: 10.1016/0026-0495(84)90063-5.
4
Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.熊去氧胆酸对慢性活动性肝炎血清肝酶及胆汁酸代谢的影响:一项剂量反应研究。
Hepatology. 1991 Feb;13(2):339-44.
5
Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.熊去氧胆酸和牛磺酸对慢性肝炎患者血清肝酶及胆汁酸的影响
Gastroenterology. 1990 Apr;98(4):1044-50. doi: 10.1016/0016-5085(90)90032-v.
6
Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones.熊去氧胆酸对胆固醇结石患者禁食和进食期间胆汁脂质偶联及胆固醇吸收的影响。
Gastroenterology. 1988 Aug;95(2):408-16. doi: 10.1016/0016-5085(88)90498-2.
7
Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.熊去氧胆酸治疗后慢性肝病患者血清和尿液中硫酸化熊去氧胆酸增加。
J Gastroenterol Hepatol. 1996 Apr;11(4):385-90. doi: 10.1111/j.1440-1746.1996.tb01388.x.
8
Hypolipidemic effects of NB-598 in dogs.
Atherosclerosis. 1991 Jun;88(2-3):183-92. doi: 10.1016/0021-9150(91)90080-m.
9
Cholesterol malabsorption in pancreatic insufficiency: effects of enzyme substitution.胰腺功能不全时的胆固醇吸收不良:酶替代疗法的效果
Gastroenterology. 1992 Feb;102(2):647-55. doi: 10.1016/0016-5085(92)90115-f.
10
The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.熊去氧胆酸对胆结石患者血清及胆汁中非胆固醇类固醇的影响。
Hepatology. 1997 Mar;25(3):514-8. doi: 10.1002/hep.510250302.

引用本文的文献

1
Regulation of Fgf15 expression in the intestine by glucocorticoid receptor.糖皮质激素受体对肠道中 Fgf15 表达的调节。
Mol Med Rep. 2019 Apr;19(4):2953-2959. doi: 10.3892/mmr.2019.9915. Epub 2019 Jan 30.
2
Clinical application of transcriptional activators of bile salt transporters.胆汁盐转运体转录激活剂的临床应用
Mol Aspects Med. 2014 Jun;37(100):57-76. doi: 10.1016/j.mam.2013.12.001. Epub 2013 Dec 12.
3
Nuclear receptors as drug targets in cholestatic liver diseases.核受体作为胆汁淤积性肝病的药物靶点。

本文引用的文献

1
Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control.松鼠猴体内胆固醇的合成:不同组织中合成的相对速率和调控机制。
J Clin Invest. 1968 Jan;47(1):166-74. doi: 10.1172/JCI105706.
2
Development of hypercholesteremia during cortisone and ACTH therapy.
J Am Med Assoc. 1950 Nov 11;144(11):909-14. doi: 10.1001/jama.1950.02920110021006.
3
Biliary excretion of bile acids and cholesterol in bile fistula rats; bile acids and steroids.胆瘘大鼠胆汁中胆汁酸和胆固醇的胆汁排泄;胆汁酸和类固醇
Clin Liver Dis. 2013 May;17(2):161-89. doi: 10.1016/j.cld.2012.12.001.
Proc Soc Exp Biol Med. 1957 Mar;94(3):578-82. doi: 10.3181/00379727-94-23018.
4
Oral ursodeoxycholic acid tolerance test in patients with digestive disease.消化系统疾病患者的口服熊去氧胆酸耐受性试验
Gastroenterol Jpn. 1981;16(5):472-7. doi: 10.1007/BF02774519.
5
Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.免疫抑制疗法对慢性活动性乙型肝炎病毒标志物的影响。
Gastroenterology. 1981 Dec;81(6):987-91.
6
Ursodeoxycholic acid oral tolerance test in patients with constitutional hyperbilirubinemias and effect of phenobarbital.先天性高胆红素血症患者的熊去氧胆酸口服耐受试验及苯巴比妥的作用
Gastroenterology. 1981 Jul;81(1):126-35.
7
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.泼尼松龙对乙肝表面抗原阳性慢性活动性肝炎的有害作用。
N Engl J Med. 1981 Feb 12;304(7):380-6. doi: 10.1056/NEJM198102123040702.
8
Steroid-induced lipemia. A complication of high-dosage corticosteroid therapy.类固醇诱导的脂血症。高剂量皮质类固醇治疗的一种并发症。
Arch Intern Med. 1970 Jan;125(1):129-34. doi: 10.1001/archinte.125.1.129.
9
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.皮质类固醇疗法治疗活动性慢性肝炎的对照前瞻性试验
Q J Med. 1971 Apr;40(158):159-85. doi: 10.1093/oxfordjournals.qjmed.a067264.
10
Cholesterol turnover in patients with chronic liver disease.慢性肝病患者的胆固醇周转率
Eur J Clin Invest. 1973 Jan;3(1):10-5.